title: Prolonged molecular remission in a newly diagnosed acute promyelocytic leukaemia with a severe cardiomyopathy using low-dose gemtuzumab ozogamicin and all-trans retinoic acid.
authors.forename: Vincenza
authors.initials: V
authors.lastname: Martini
authors.forename: Clara
authors.initials: C
authors.lastname: Minotti
authors.forename: Massimo
authors.initials: M
authors.lastname: Breccia
authors.forename: Gioia
authors.initials: G
authors.lastname: De Angelis
authors.forename: Sonia
authors.initials: S
authors.lastname: Buffolino
authors.forename: Montano
authors.initials: M
authors.lastname: Mariella
authors.forename: Francesco
authors.initials: F
authors.lastname: Lo-Coco
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Avvisati
authors.forename: Giuseppe
authors.initials: G
authors.lastname: Cimino
mesh_terms: D000617:Aminoglycosides / Q000627:therapeutic use*; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use; D000077237:Arsenic Trioxide; D001152:Arsenicals / Q000627:therapeutic use; D009202:Cardiomyopathies / Q000150:complications* / Q000473:pathology / Q000503:physiopathology; D004359:Drug Therapy, Combination; D004452:Echocardiography; D000079982:Gemtuzumab; D006801:Humans; D015473:Leukemia, Promyelocytic, Acute / Q000150:complications / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D010087:Oxides / Q000627:therapeutic use; D012074:Remission Induction; D020133:Reverse Transcriptase Polymerase Chain Reaction; D016896:Treatment Outcome; D014212:Tretinoin / Q000627:therapeutic use*
chemical_list: D000617:Aminoglycosides; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D001152:Arsenicals; D015514:Oncogene Proteins, Fusion; D010087:Oxides; C093476:promyelocytic leukemia-retinoic acid receptor alpha fusion oncoprotein; D014212:Tretinoin; D000079982:Gemtuzumab; D000077237:Arsenic Trioxide